ProPublica published a list of investigations you may have missed due to America's governing turmoil. One is the story of Zolgensma, a gene therapy drug which gives baby's born with a rare disease a real chance to grow up and live normal lives. Despite being developed with help from taxpayers and nonprofit charities, the drug's maker debuted the drug with a $2-million per dose price tag, which set the stage for other gene therapy drugs to also have million dollar prices. ProPublica dug into the records to show how the drug was developed and why it debuted at such a high cost. "Its story upends the widely held conception that high prices reflect huge industry investments in innovation."
Drudge Retort Headlines
Pam Bondi Hearing Devolves into Shouting Matches (42 comments)
Pro-Trump Town Finds Out (32 comments)
House Passes Bill that Could Create Voting Barriers for Married Women (30 comments)
Grand Jury Fails to Indict Democrats from 'illegal orders' Video, Rebuking DOJ (28 comments)
FAA Suddenly Drops Unprecedented Air Restrictions Over El Paso, Southern New Mexico (25 comments)
Trump Says China Will Terminate Hockey in Canada (25 comments)
Trump told Palm Beach Police Chief 'everyone' Knew about Epstein (23 comments)
American Optimism Crashes to All-Time Low Under Trump (18 comments)
The Epstein Files Congress Sees But You Don't. (18 comments)
Immigrants Use Less Welfare at Every Income Level (17 comments)